Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23302882)


Henipavirus pathogenesis in human respiratory epithelial cells.

Escaffre O, Borisevich V, Carmical JR, Prusak D, Prescott J, Feldmann H, Rockx B.

J Virol. 2013 Mar;87(6):3284-94. doi: 10.1128/JVI.02576-12. Epub 2013 Jan 9.


Pathogenesis of Hendra and Nipah virus infection in humans.

Escaffre O, Borisevich V, Rockx B.

J Infect Dev Ctries. 2013 Apr 17;7(4):308-11. doi: 10.3855/jidc.3648. Review.


A human lung xenograft mouse model of Nipah virus infection.

Valbuena G, Halliday H, Borisevich V, Goez Y, Rockx B.

PLoS Pathog. 2014 Apr 3;10(4):e1004063. doi: 10.1371/journal.ppat.1004063. eCollection 2014 Apr.


Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, Gao J, Wu P, Lee B, Freiberg AN.

J Virol. 2015 Jan 15;89(2):1242-53. doi: 10.1128/JVI.02583-14. Epub 2014 Nov 12.


Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster.

DeBuysscher BL, de Wit E, Munster VJ, Scott D, Feldmann H, Prescott J.

PLoS Negl Trop Dis. 2013;7(1):e2024. doi: 10.1371/journal.pntd.0002024. Epub 2013 Jan 17.


Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.

Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H.

J Virol. 2011 Aug;85(15):7658-71. doi: 10.1128/JVI.00473-11. Epub 2011 May 18.


Type I interferon signaling protects mice from lethal henipavirus infection.

Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A, Raoul H, Horvat B.

J Infect Dis. 2013 Jan 1;207(1):142-51. doi: 10.1093/infdis/jis653. Epub 2012 Oct 22.


Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.

Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC.

J Virol. 2005 Jun;79(11):6690-702.


Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.

Guillaume V, Wong KT, Looi RY, Georges-Courbot MC, Barrot L, Buckland R, Wild TF, Horvat B.

Virology. 2009 May 10;387(2):459-65. doi: 10.1016/j.virol.2009.03.001. Epub 2009 Mar 28.


Hendra and Nipah viruses: why are they so deadly?

Marsh GA, Wang LF.

Curr Opin Virol. 2012 Jun;2(3):242-7. doi: 10.1016/j.coviro.2012.03.006. Epub 2012 Apr 5. Review.


Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.

Sawatsky B, Grolla A, Kuzenko N, Weingartl H, Czub M.

J Gen Virol. 2007 Feb;88(Pt 2):582-91.


The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus?

Breed AC, Meers J, Sendow I, Bossart KN, Barr JA, Smith I, Wacharapluesadee S, Wang L, Field HE.

PLoS One. 2013 Apr 24;8(4):e61316. doi: 10.1371/journal.pone.0061316. Print 2013.


Epidemiology of henipavirus disease in humans.

Luby SP, Gurley ES.

Curr Top Microbiol Immunol. 2012;359:25-40. doi: 10.1007/82_2012_207. Review.


Subclinical infection without encephalitis in mice following intranasal exposure to Nipah virus-Malaysia and Nipah virus-Bangladesh.

Dups J, Middleton D, Long F, Arkinstall R, Marsh GA, Wang LF.

Virol J. 2014 Jun 2;11:102. doi: 10.1186/1743-422X-11-102.


Hendra and Nipah viruses: pathogenesis and therapeutics.

Eaton BT, Broder CC, Wang LF.

Curr Mol Med. 2005 Dec;5(8):805-16. Review.


Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission.

Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Daszak P; Henipavirus Ecology Research Group.

Am J Trop Med Hyg. 2011 Nov;85(5):946-51. doi: 10.4269/ajtmh.2011.10-0567.


Animal challenge models of henipavirus infection and pathogenesis.

Geisbert TW, Feldmann H, Broder CC.

Curr Top Microbiol Immunol. 2012;359:153-77. doi: 10.1007/82_2012_208. Review.


Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.

Negrete OA, Chu D, Aguilar HC, Lee B.

J Virol. 2007 Oct;81(19):10804-14. Epub 2007 Jul 25.


A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.

Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC, Feldmann H, Geisbert TW.

Sci Transl Med. 2012 Aug 8;4(146):146ra107. doi: 10.1126/scitranslmed.3004241.


Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.

Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS.

J Infect Dis. 2008 Mar 15;197(6):846-53. doi: 10.1086/528801.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk